Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

AST SpaceMobile stock slides after Scotiabank downgrade calls valuation “irrational”

AST SpaceMobile stock slides after Scotiabank downgrade calls valuation “irrational”

New York, Jan 7, 2026, 12:42 (EST) — Regular session AST SpaceMobile, Inc. (ASTS) fell 8.5% to $89.18 in midday trading on Wednesday after Scotiabank cut the satellite communications company to sector underperform. The stock opened at $91 and hit a session low of $88.49 as volume rose past 12.3 million shares. The downgrade hits after a sharp run that has pushed the stock close to its highs and made valuation the central argument. Shares have more than tripled over the past 12 months, even though the company is not expected to post positive operating profit until 2027. Barron’s Scotiabank
Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

New York, Jan 7, 2026, 12:23 (EST) — Regular session Mastercard Incorporated (NYSE:MA) shares rose 0.7% to $584.60 on Wednesday, after trading between $577.52 and $584.60. About 1.36 million shares had changed hands by late morning. The move came in a mixed session for U.S. stocks. The S&P 500-tracking SPY was up about 0.3% while the Dow-linked DIA slipped 0.1%; tech-heavy QQQ gained about 0.7%. Labor data kept risk appetite in check ahead of Friday’s government jobs report. U.S. private payrolls rose 41,000 in December, below economists’ forecasts, ADP data showed. Morgan Stanley kept Mastercard rated “overweight” — a call
Uber stock gains as CES robotaxi testing update puts autonomy back in focus

Uber stock gains as CES robotaxi testing update puts autonomy back in focus

NEW YORK, Jan 7, 2026, 12:14 EST — Regular session Uber Technologies (UBER) shares climbed on Wednesday, up about 1.7% at $87.03 in midday New York trading, after the company and partners detailed progress on a planned robotaxi service tied to the Uber app. Source The move landed as U.S. stocks turned mixed and investors sized up fresh labor data ahead of Friday’s monthly jobs report, a potential swing factor for rate bets and high-growth names. Source For Uber, autonomy is back in the conversation because it sits at the intersection of two things shareholders keep circling: whether the company
Intel stock jumps 8% on CES 2026 18A chip debut as INTC investors eye the next catalyst

Intel stock jumps 8% on CES 2026 18A chip debut as INTC investors eye the next catalyst

New York, January 7, 2026, 11:40 (EST) — Regular session Intel shares jumped about 8% on Wednesday after the chipmaker showcased laptop processors built on its new “18A” manufacturing technology at the CES trade show in Las Vegas. The stock was up 8.3% at $43.37 in late-morning trade, after topping $44.55. Investing.com The move matters now because 18A — Intel’s label for its next chipmaking process — sits at the center of its turnaround pitch, including hopes of winning more advanced manufacturing work. Intel said its Core Ultra Series 3 line is the first compute platform built on 18A, which
Exxon Mobil stock slides as Trump’s Venezuela oil plan drags crude, filing due after close

Exxon Mobil stock slides as Trump’s Venezuela oil plan drags crude, filing due after close

NEW YORK, Jan 7, 2026, 11:38 EST — Regular session Exxon Mobil Corporation shares fell on Wednesday as oil prices slid and traders weighed fresh signals on Venezuelan supply. The stock was down $1.34, or 1.1%, at $119.71, after touching an intraday low of $118.96. Chevron was little changed while ConocoPhillips fell about 1%. The drop tracked crude after U.S. President Donald Trump said Venezuela would “turn over” between 30 million and 50 million barrels of sanctioned oil to the United States. Brent was down about 0.7% near $60 a barrel and U.S. West Texas Intermediate was off about 1.3%
Eli Lilly stock climbs on Ventyx buyout talk as dealmaking takes center stage

Eli Lilly stock climbs on Ventyx buyout talk as dealmaking takes center stage

New York, January 7, 2026, 11:41 EST — Regular session. Eli Lilly and Company shares were up 3.3% at $1,099.44 in late morning trade, pushing back toward the $1,100 level as investors cheered fresh deal chatter around the drugmaker’s pipeline. (https://www.reuters.com/markets/companies/LLY.N/) The lift matters now because the market is watching how Lilly defends its growth run while competitors push pill versions of obesity drugs and pricing stays in flux. Investors have rewarded companies that can keep adding late-stage shots on goal without derailing margins. The Wall Street Journal reported Lilly is in advanced talks to buy Ventyx Biosciences for more
Oracle stock (ORCL) barely moves as Jefferies sticks with $400 target

Oracle stock (ORCL) barely moves as Jefferies sticks with $400 target

New York, January 7, 2026, 11:40 ET — Regular session Oracle Corp shares slipped 0.2% to $193.44 in late-morning trading on Wednesday, after Jefferies reiterated a Buy rating and kept a $400 price target in a 2026 software outlook. Jefferies analyst Brent Thill said OpenAI accounts for 57% of Oracle’s contract backlog and argued the stock can rebound after a roughly 40% slide tied to worry about AI spending and debt. Investors The call matters because Oracle has become a test case for how much the market will pay for AI infrastructure inside a mature software name. Investors want proof
Chevron stock edges higher as $22 billion Lukoil-bid talk collides with Venezuela supply headlines

Chevron stock edges higher as $22 billion Lukoil-bid talk collides with Venezuela supply headlines

New York, Jan 7, 2026, 11:28 EST — Regular session Chevron Corp shares inched up on Wednesday as investors digested a report that private equity group Quantum Energy Partners is working on a bid that could involve Chevron for the international assets of Russia’s Lukoil, even as weaker oil prices kept a lid on energy stocks more broadly. The stock was up 0.1% at $156.68 by late morning in New York, after trading between $155.19 and $159.60; Exxon Mobil was down about 1.2%, ConocoPhillips fell 1.3% and Occidental Petroleum slid 1.5%. Reuters The timing matters. A possible transaction for sanctioned-era
AppLovin (APP) stock rises as Piper Sandler sticks with $800 target and BofA keeps $860 view

AppLovin (APP) stock rises as Piper Sandler sticks with $800 target and BofA keeps $860 view

New York, January 7, 2026, 11:36 EST — Regular session AppLovin (APP.O) shares rose about 2% on Wednesday, building on a choppy start to the year as fresh analyst notes kept attention on the company’s push into e-commerce advertising. The stock was up at $629.57, while the S&P 500 was little changed and the Nasdaq-100 ETF edged higher; rival Trade Desk fell. The move matters because AppLovin’s next leg is still being priced in. Bulls are betting the company can broaden beyond mobile-game ads into web and e-commerce budgets, and the next earnings call is expected to put real numbers
SoFi stock slips again as share-sale overhang hangs on; Jan. 30 earnings next

SoFi stock slips again as share-sale overhang hangs on; Jan. 30 earnings next

NEW YORK, Jan 7, 2026, 11:26 (EST) — Regular session SoFi Technologies shares were down about 1.4% at $26.61 by 11:26 a.m. EST on Wednesday, extending recent weakness as investors absorbed fresh details on stock sold into the market. A regulatory filing showed the underwriters of SoFi’s December share sale exercised their option to buy additional stock, and the company completed that extra issuance on Jan. 5. The “greenshoe” option — a standard clause that lets banks buy more shares — pushed total shares sold in the offering to 57,754,660 at $27.50 each, with Goldman Sachs, BofA Securities, Citigroup, Deutsche
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

New York, January 7, 2026, 11:10 EST — Regular session UnitedHealth Group Incorporated shares fell more than 2% on Wednesday, tracking a broader retreat in managed-care insurers. The stock was down $8.53 at $340.44 in late morning trading, while Humana slid 1.4% and Cigna dropped 2.1%. The move comes with investors bracing for UnitedHealth’s full-year results later this month, when the company is due to set out 2026 guidance. A key focus is the medical care ratio — the share of premium revenue that goes to medical claims — after a stretch of elevated utilization across the sector. UnitedHealth Group
Lam Research stock slips after two-day rally as traders weigh fresh Buy call and CES headlines

Lam Research stock slips after two-day rally as traders weigh fresh Buy call and CES headlines

NEW YORK, Jan 7, 2026, 10:51 EST — Regular session Shares of Lam Research Corp (LRCX) fell about 2.5% to $201.86 in morning trading on Wednesday, giving back part of a two-day rally in semiconductor equipment stocks. The timing matters because the trade in chip gear has turned fast this week, with investors leaning into names tied to artificial-intelligence-related chip buildouts as CES kicks off in Las Vegas. The group has also started to draw fresh analyst attention ahead of earnings season. Reuters+1 Aletheia Capital on Tuesday initiated coverage of Lam with a Buy rating and a $260 price target.

Stock Market Today

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

7 February 2026
Keppel shares closed at S$11.64 on Friday, up 0.17%, after surging 6.1% the previous day on stronger FY2025 profit and a larger dividend plan. The company bought back 151,400 shares for about S$1.74 million. Keppel reported a 29% rise in full-year profit to S$1.02 billion and proposed a total distribution of 47 cents per share, including a special dividend partly paid in Keppel REIT units.
Go toTop